Lessons from the HEALEY adaptive platform trial in amyotrophic lateral sclerosis

IF 17 Q1 CELL BIOLOGY Nature aging Pub Date : 2024-11-01 DOI:10.1038/s43587-024-00740-x
Sabrina Paganoni, Brittney Harkey, Elisa Giacomelli, Merit Cudkowicz, on behalf of the HEALEY ALS Platform Trial Study Group
{"title":"Lessons from the HEALEY adaptive platform trial in amyotrophic lateral sclerosis","authors":"Sabrina Paganoni, Brittney Harkey, Elisa Giacomelli, Merit Cudkowicz, on behalf of the HEALEY ALS Platform Trial Study Group","doi":"10.1038/s43587-024-00740-x","DOIUrl":null,"url":null,"abstract":"Platform trials present potential advantages over stand-alone clinical trials. Here, we describe the operational framework of the HEALEY Amyotrophic Lateral Sclerosis Platform Trial, which enables an adaptable operational infrastructure, concurrent enrolment into four distinct regimens and an accelerated start-up time for a new regimen added after initial trial launch.","PeriodicalId":94150,"journal":{"name":"Nature aging","volume":"4 11","pages":"1512-1515"},"PeriodicalIF":17.0000,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nature aging","FirstCategoryId":"1085","ListUrlMain":"https://www.nature.com/articles/s43587-024-00740-x","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CELL BIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Platform trials present potential advantages over stand-alone clinical trials. Here, we describe the operational framework of the HEALEY Amyotrophic Lateral Sclerosis Platform Trial, which enables an adaptable operational infrastructure, concurrent enrolment into four distinct regimens and an accelerated start-up time for a new regimen added after initial trial launch.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
肌萎缩性脊髓侧索硬化症 HEALEY 适应性平台试验的启示。
与独立的临床试验相比,平台试验具有潜在的优势。在此,我们介绍了 HEALEY 肌萎缩侧索硬化症平台试验的运行框架,该框架可实现适应性强的运行基础设施、四种不同治疗方案的同时入组,以及在初始试验启动后加快新治疗方案的启动时间。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
14.70
自引率
0.00%
发文量
0
期刊最新文献
Effect of nicotinamide riboside on airway inflammation in COPD: a randomized, placebo-controlled trial. Reactivation of senescence-associated endogenous retroviruses by ATF3 drives interferon signaling in aging. Brain-wide alterations revealed by spatial transcriptomics and proteomics in COVID-19 infection Clearance of p21 highly expressing senescent cells accelerates cutaneous wound healing. Diagnosis of Alzheimer’s disease using plasma biomarkers adjusted to clinical probability
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1